Prosecution Insights
Last updated: April 19, 2026
Application No. 18/296,660

STEERABLE MEDICAL DEVICE, HANDLE FOR A MEDICAL DEVICE, AND METHOD FOR OPERATING A MEDICAL DEVICE

Non-Final OA §102
Filed
Apr 06, 2023
Examiner
BOUCHELLE, LAURA A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
BOSTON SCIENTIFIC CORPORATION
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
90%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allow Rate
952 granted / 1188 resolved
+10.1% vs TC avg
Moderate +10% lift
Without
With
+10.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
47 currently pending
Career history
1235
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
43.9%
+3.9% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1188 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Species A in the reply filed on 1/8/2026 is acknowledged. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-3, 9-12, 18, 19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Scheibe et al (US 2012/0089125). Regarding claim 1, Scheibe discloses a steerable medical device (fig. 1) comprising: an elongate tool 14; a handle 12 mounted to the tool and having a handle body 12A, 12B and a knob 44 that is rotatable with respect to the handle body (fig. 1; page 3, para. 0042); a first gear 42 housed within the handle and associated with the knob (fig. 2; page 2, para. 0032), whereby rotation of the knob drives rotation of the first gear (page 2, para. 0033; fig. 2); a slider 48 housed within the handle body and including a rack 50 engaged with the first gear (fig. 2; page 2, para. 0035), whereby rotation of the first gear drives translation of the slider with respect to the handle body (page 3, para. 0045); and at least one control wire 58 coupled to the slider and to the tool (pages 2-3, para. 0038), whereby translation of the slider causes tensioning of the control wire, and tensioning of the control wire causes deflection of the tool (page 3, para. 0045). Regarding claim 2, Scheibe discloses that the handle extends along a handle axis, and the slider is translatable along the handle axis (fig. 2). Regarding claim 3, Scheibe discloses that knob is rotatable about the handle axis (fig. 1), and the first gear 42 is a worm screw that is rotatable about the handle axis (fig. 2: lead screw is a worm gear). Regarding claim 9, Scheibe discloses that the tool is a sheath 14 (page 2, para. 0025). Regarding claim 10, Scheibe discloses a handle 12 for a steerable medical device (fig. 1), the handle comprising: a handle body 12A, 12B and a knob 44 that is rotatable with respect to the handle body (fig. 1; page 3, para. 0042); a first gear 42 housed within the handle and associated with the knob (fig. 2; page 2, para. 0032), whereby rotation of the knob drives rotation of the first gear (fig. 2; page 2, para. 0035); a slider 48 housed within the handle body and including a rack 50 engaged with the first gear, whereby rotation of the first gear drives translation of the slider with respect to the handle body (page 3, para. 0045); and at least one control wire 58 coupled to the slider (pages 2-3, para. 0038), whereby translation of the slider causes tensioning of the control wire (page 3, para. 0045). Regarding claim 11, Scheibe discloses that the handle extends along a handle axis, and the slider is translatable along the handle axis (fig. 2). Regarding claim 12, Scheibe discloses that the knob is rotatable about the handle axis (fig. 1), and the first gear is a worm screw is rotatable about the handle axis (fig. 2: lead screw is a worm gear). Regarding claim 18, Scheibe discloses a method for operating a medical device, the method comprising: rotating a knob 44 of a handle 12 (page 3, para. 0045); transmitting rotation of the knob to a first gear 42 associated with the knob (page 3, para. 0045); engaging the first gear with a rack 50 of a slider 48 to cause translation of the slider by rotation of the first gear (page 3, para. 0045); causing tensioning of a control wire 58 by translation of the slider; and causing deflection of a tool by tensioning of the control wire (page 3, para. 0045). Regarding claim 19, Scheibe discloses that the first gear is a worm gear (fig. 2: lead screw 42 is a worm gear), step a. comprises rotating the knob about a handle axis (fig. 2), and step b. comprises rotating the worm gear about the handle axis (fig. 2). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAURA A BOUCHELLE whose telephone number is (571)272-2125. The examiner can normally be reached Mon-Fri 8:00-5:00 CST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. LAURA A. BOUCHELLE Primary Examiner Art Unit 3783 /LAURA A BOUCHELLE/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Apr 06, 2023
Application Filed
Jan 15, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594377
SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION
2y 5m to grant Granted Apr 07, 2026
Patent 12589205
WET INJECTION DETECTION AND PREVENTION SYSTEM AND METHOD
2y 5m to grant Granted Mar 31, 2026
Patent 12589025
INTRAOCULAR DEVICES, SYSTEMS, AND METHODS
2y 5m to grant Granted Mar 31, 2026
Patent 12589026
MICRO DOSING DEVICE AND METHOD OF ASSEMBLY OF THE MICRO DOSING DEVICE
2y 5m to grant Granted Mar 31, 2026
Patent 12589221
MECHANICALLY-DECOUPLED ACTUATION FOR ROBOTIC CATHETER SYSTEM
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
90%
With Interview (+10.3%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 1188 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month